-
Sep 14, 2026Webinar Recap: Molecular Imaging in NHP Models For Translational Drug Develop...Explore how molecular imaging in NHP models supports biodistribution, target engagement, PK/PD, dosimetry, and longitudinal translational drug development. -
Sep 23, 2026Why Good In Vitro Data May Underperform In Vivo | Prisys BiotechExplore why strong in vitro results may not translate directly to in vivo exposure and pharmacological activity across different drug modalities. -
Sep 21, 2026Whole-Body Biodistribution Imaging in NHPs | 125I SPECTLearn how 125I molecular imaging enables longitudinal whole-body biodistribution assessment and organ-level drug distribution analysis in NHP studies. -
Sep 20, 2026How To Interpret PK Parameters in Preclinical Animal StudiesLearn how Cmax, AUC, Tmax, half-life, clearance and other PK parameters are interpreted in preclinical animal studies and PK/PD research. -
Sep 09, 2026Immuno-PET in NHP Models For Antibody DevelopmentLearn how Immuno-PET in NHP models evaluates antibody biodistribution, tissue accessibility, and target engagement for translational drug development. -
Sep 04, 2026Why Good In Vitro Data Can Fail In Vivo: Rethinking DMPK Across Drug ModalitiesWhy do promising in vitro results fail in vivo? Explore how DMPK challenges differ across small molecules, antibodies, ADCs, peptides, and nucleic acids. -
Sep 01, 2026Imaging-Based PK/PD in Non-Human PrimatesLearn how imaging-based PK/PD in NHPs complements plasma PK by evaluating tissue distribution, target engagement, and pharmacodynamic responses.
-
Aug 28, 2026Why Animal Models Succeed Or Fail in Drug DevelopmentWhen each model is selected for a clearly defined purpose, preclinical research becomes more than a demonstration of efficacy
-
Aug 26, 2026Quantitative PET Target Engagement in NHPs For CNS DrugsLearn how quantitative PET in non-human primates measures brain exposure and target occupancy to support CNS drug development, dose selection, and translation. -
Aug 21, 2026From Video To Data: 3D AI Tracking For NHP BehaviorLearn how markerless 3D AI tracking converts NHP video into quantitative behavioral endpoints for CNS, pain, pruritus, and translational drug research. -
Aug 19, 2026PET Biodistribution Imaging in Non-Human PrimatesLearn how PET imaging enables longitudinal biodistribution studies in NHPs, with applications in vaccines, nanoparticles, biologics, and translational drug development. -
Aug 14, 2026PBPK Vs. Compartmental Models: Why PBPK MattersLearn how PBPK modeling differs from traditional PK models and supports DDI, organ impairment, pediatric dosing, food-effect, and regulatory decisions.
